Non-wearable Blood Glucose Monitoring Systems are blood glucose monitoring systems that cannot be worn on the body.
The global Non-wearable Blood Glucose Monitoring Systems market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Non-wearable Blood Glucose Monitoring Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Non-wearable Blood Glucose Monitoring Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Non-wearable Blood Glucose Monitoring Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Non-wearable Blood Glucose Monitoring Systems include Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices and Nova Biomedical, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Non-wearable Blood Glucose Monitoring Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Non-wearable Blood Glucose Monitoring Systems, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Non-wearable Blood Glucose Monitoring Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-wearable Blood Glucose Monitoring Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Non-wearable Blood Glucose Monitoring Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Non-wearable Blood Glucose Monitoring Systems sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices and Nova Biomedical, etc.
By Company
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Segment by Type
Blood Glucose Meter
Blood Glucose Testing Strips
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Non-wearable Blood Glucose Monitoring Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Non-wearable Blood Glucose Monitoring Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-wearable Blood Glucose Monitoring Systems sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Non-wearable Blood Glucose Monitoring Systems Product Introduction
1.2 Market by Type
1.2.1 Global Non-wearable Blood Glucose Monitoring Systems Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Blood Glucose Meter
1.2.3 Blood Glucose Testing Strips
1.3 Market by Application
1.3.1 Global Non-wearable Blood Glucose Monitoring Systems Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-wearable Blood Glucose Monitoring Systems Sales Estimates and Forecasts 2018-2029
2.2 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Region
2.2.1 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Region (2018-2023)
2.2.3 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Region (2024-2029)
2.2.4 Global Non-wearable Blood Glucose Monitoring Systems Revenue Market Share by Region (2018-2029)
2.3 Global Non-wearable Blood Glucose Monitoring Systems Sales Estimates and Forecasts 2018-2029
2.4 Global Non-wearable Blood Glucose Monitoring Systems Sales by Region
2.4.1 Global Non-wearable Blood Glucose Monitoring Systems Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Non-wearable Blood Glucose Monitoring Systems Sales by Region (2018-2023)
2.4.3 Global Non-wearable Blood Glucose Monitoring Systems Sales by Region (2024-2029)
2.4.4 Global Non-wearable Blood Glucose Monitoring Systems Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Non-wearable Blood Glucose Monitoring Systems Sales by Manufacturers
3.1.1 Global Non-wearable Blood Glucose Monitoring Systems Sales by Manufacturers (2018-2023)
3.1.2 Global Non-wearable Blood Glucose Monitoring Systems Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-wearable Blood Glucose Monitoring Systems in 2022
3.2 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Manufacturers
3.2.1 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Manufacturers (2018-2023)
3.2.2 Global Non-wearable Blood Glucose Monitoring Systems Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Non-wearable Blood Glucose Monitoring Systems Revenue in 2022
3.3 Global Key Players of Non-wearable Blood Glucose Monitoring Systems, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Non-wearable Blood Glucose Monitoring Systems Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Non-wearable Blood Glucose Monitoring Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Non-wearable Blood Glucose Monitoring Systems, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Non-wearable Blood Glucose Monitoring Systems, Product Offered and Application
3.8 Global Key Manufacturers of Non-wearable Blood Glucose Monitoring Systems, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-wearable Blood Glucose Monitoring Systems Sales by Type
4.1.1 Global Non-wearable Blood Glucose Monitoring Systems Historical Sales by Type (2018-2023)
4.1.2 Global Non-wearable Blood Glucose Monitoring Systems Forecasted Sales by Type (2024-2029)
4.1.3 Global Non-wearable Blood Glucose Monitoring Systems Sales Market Share by Type (2018-2029)
4.2 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Type
4.2.1 Global Non-wearable Blood Glucose Monitoring Systems Historical Revenue by Type (2018-2023)
4.2.2 Global Non-wearable Blood Glucose Monitoring Systems Forecasted Revenue by Type (2024-2029)
4.2.3 Global Non-wearable Blood Glucose Monitoring Systems Revenue Market Share by Type (2018-2029)
4.3 Global Non-wearable Blood Glucose Monitoring Systems Price by Type
4.3.1 Global Non-wearable Blood Glucose Monitoring Systems Price by Type (2018-2023)
4.3.2 Global Non-wearable Blood Glucose Monitoring Systems Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Non-wearable Blood Glucose Monitoring Systems Sales by Application
5.1.1 Global Non-wearable Blood Glucose Monitoring Systems Historical Sales by Application (2018-2023)
5.1.2 Global Non-wearable Blood Glucose Monitoring Systems Forecasted Sales by Application (2024-2029)
5.1.3 Global Non-wearable Blood Glucose Monitoring Systems Sales Market Share by Application (2018-2029)
5.2 Global Non-wearable Blood Glucose Monitoring Systems Revenue by Application
5.2.1 Global Non-wearable Blood Glucose Monitoring Systems Historical Revenue by Application (2018-2023)
5.2.2 Global Non-wearable Blood Glucose Monitoring Systems Forecasted Revenue by Application (2024-2029)
5.2.3 Global Non-wearable Blood Glucose Monitoring Systems Revenue Market Share by Application (2018-2029)
5.3 Global Non-wearable Blood Glucose Monitoring Systems Price by Application
5.3.1 Global Non-wearable Blood Glucose Monitoring Systems Price by Application (2018-2023)
5.3.2 Global Non-wearable Blood Glucose Monitoring Systems Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Non-wearable Blood Glucose Monitoring Systems Market Size by Type
6.1.1 US & Canada Non-wearable Blood Glucose Monitoring Systems Sales by Type (2018-2029)
6.1.2 US & Canada Non-wearable Blood Glucose Monitoring Systems Revenue by Type (2018-2029)
6.2 US & Canada Non-wearable Blood Glucose Monitoring Systems Market Size by Application
6.2.1 US & Canada Non-wearable Blood Glucose Monitoring Systems Sales by Application (2018-2029)
6.2.2 US & Canada Non-wearable Blood Glucose Monitoring Systems Revenue by Application (2018-2029)
6.3 US & Canada Non-wearable Blood Glucose Monitoring Systems Market Size by Country
6.3.1 US & Canada Non-wearable Blood Glucose Monitoring Systems Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Non-wearable Blood Glucose Monitoring Systems Sales by Country (2018-2029)
6.3.3 US & Canada Non-wearable Blood Glucose Monitoring Systems Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Non-wearable Blood Glucose Monitoring Systems Market Size by Type
7.1.1 Europe Non-wearable Blood Glucose Monitoring Systems Sales by Type (2018-2029)
7.1.2 Europe Non-wearable Blood Glucose Monitoring Systems Revenue by Type (2018-2029)
7.2 Europe Non-wearable Blood Glucose Monitoring Systems Market Size by Application
7.2.1 Europe Non-wearable Blood Glucose Monitoring Systems Sales by Application (2018-2029)
7.2.2 Europe Non-wearable Blood Glucose Monitoring Systems Revenue by Application (2018-2029)
7.3 Europe Non-wearable Blood Glucose Monitoring Systems Market Size by Country
7.3.1 Europe Non-wearable Blood Glucose Monitoring Systems Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Non-wearable Blood Glucose Monitoring Systems Sales by Country (2018-2029)
7.3.3 Europe Non-wearable Blood Glucose Monitoring Systems Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Non-wearable Blood Glucose Monitoring Systems Market Size
8.1.1 China Non-wearable Blood Glucose Monitoring Systems Sales (2018-2029)
8.1.2 China Non-wearable Blood Glucose Monitoring Systems Revenue (2018-2029)
8.2 China Non-wearable Blood Glucose Monitoring Systems Market Size by Application
8.2.1 China Non-wearable Blood Glucose Monitoring Systems Sales by Application (2018-2029)
8.2.2 China Non-wearable Blood Glucose Monitoring Systems Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Non-wearable Blood Glucose Monitoring Systems Market Size by Type
9.1.1 Asia Non-wearable Blood Glucose Monitoring Systems Sales by Type (2018-2029)
9.1.2 Asia Non-wearable Blood Glucose Monitoring Systems Revenue by Type (2018-2029)
9.2 Asia Non-wearable Blood Glucose Monitoring Systems Market Size by Application
9.2.1 Asia Non-wearable Blood Glucose Monitoring Systems Sales by Application (2018-2029)
9.2.2 Asia Non-wearable Blood Glucose Monitoring Systems Revenue by Application (2018-2029)
9.3 Asia Non-wearable Blood Glucose Monitoring Systems Sales by Region
9.3.1 Asia Non-wearable Blood Glucose Monitoring Systems Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Non-wearable Blood Glucose Monitoring Systems Revenue by Region (2018-2029)
9.3.3 Asia Non-wearable Blood Glucose Monitoring Systems Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Market Size by Type
10.1.1 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Market Size by Application
10.2.1 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Sales by Country
10.3.1 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Non-wearable Blood Glucose Monitoring Systems Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Abbott Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Medtronic
11.2.1 Medtronic Company Information
11.2.2 Medtronic Overview
11.2.3 Medtronic Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Medtronic Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Roche Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Information
11.4.2 Bayer AG Overview
11.4.3 Bayer AG Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Bayer AG Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer AG Recent Developments
11.5 B. Braun
11.5.1 B. Braun Company Information
11.5.2 B. Braun Overview
11.5.3 B. Braun Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 B. Braun Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Recent Developments
11.6 Nipro Diagnostics
11.6.1 Nipro Diagnostics Company Information
11.6.2 Nipro Diagnostics Overview
11.6.3 Nipro Diagnostics Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Nipro Diagnostics Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nipro Diagnostics Recent Developments
11.7 Life Scan Inc.(J&J)
11.7.1 Life Scan Inc.(J&J) Company Information
11.7.2 Life Scan Inc.(J&J) Overview
11.7.3 Life Scan Inc.(J&J) Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Life Scan Inc.(J&J) Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Life Scan Inc.(J&J) Recent Developments
11.8 Arkray Devices
11.8.1 Arkray Devices Company Information
11.8.2 Arkray Devices Overview
11.8.3 Arkray Devices Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Arkray Devices Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Arkray Devices Recent Developments
11.9 Nova Biomedical
11.9.1 Nova Biomedical Company Information
11.9.2 Nova Biomedical Overview
11.9.3 Nova Biomedical Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Nova Biomedical Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nova Biomedical Recent Developments
11.10 Bionime Corporation
11.10.1 Bionime Corporation Company Information
11.10.2 Bionime Corporation Overview
11.10.3 Bionime Corporation Non-wearable Blood Glucose Monitoring Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Bionime Corporation Non-wearable Blood Glucose Monitoring Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bionime Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-wearable Blood Glucose Monitoring Systems Industry Chain Analysis
12.2 Non-wearable Blood Glucose Monitoring Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-wearable Blood Glucose Monitoring Systems Production Mode & Process
12.4 Non-wearable Blood Glucose Monitoring Systems Sales and Marketing
12.4.1 Non-wearable Blood Glucose Monitoring Systems Sales Channels
12.4.2 Non-wearable Blood Glucose Monitoring Systems Distributors
12.5 Non-wearable Blood Glucose Monitoring Systems Customers
13 Market Dynamics
13.1 Non-wearable Blood Glucose Monitoring Systems Industry Trends
13.2 Non-wearable Blood Glucose Monitoring Systems Market Drivers
13.3 Non-wearable Blood Glucose Monitoring Systems Market Challenges
13.4 Non-wearable Blood Glucose Monitoring Systems Market Restraints
14 Key Findings in The Global Non-wearable Blood Glucose Monitoring Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
听
听
*If Applicable.
